Clinical Trial Update: Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating the effect of metformin on atherosclerotic cardiovascular outcomes in people with prediabetes; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Prediabetes

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Prediabetic State, Atherosclerosis | Phase 4 | Status: RECRUITING